慢性乙肝和脂肪肝：在临床管理问题。

StephenW

Clin Res Hepatol Gastroenterol. 2016 Feb 2. pii: S2210-7401(16)00002-4. doi: 10.1016/j.clinre.2015.12.011. [Epub ahead of print]
Chronic hepatitis B and fatty liver: Issues in clinical management.Kumar R1, Boon-Bee Goh G2.
Author information

• 1Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore; Cancer research centre of Lyon (CRCL), INSERM U1052, Lyon, France. Electronic address: [email protected].
• 2Department of Gastroenterology and Hepatology, Singapore General Hospital, Singapore, Singapore.
  

AbstractWith an increasing incidence of non-alcoholic fatty livers, the existence of concomitant hepatitis B and fatty liver is becoming more common in clinical practice. In clinical practice, the concomitant existence of hepatitis B and fatty livers raises practical issues in clinical management. It becomes more difficult for the clinician to decide on the mode of treatment in the case of elevated Alanine aminotransferase (ALT) and in deciding potential causes, whether they are related to chronic hepatitis B or to non-alcoholic steatohepatitis (NASH). With evolving changes in the practice and knowledge of non-alcoholic fatty liver disease and chronic hepatitis B, clinical judgment on the predominant disease becomes essential for their coexistence. This short review is aimed at reviewing the evidence available on the frequency of the two diseases existing concomitantly, possible ways of differentiating the two, the prognosis, outcomes of treatment and a possible common pathway.
Copyright © 2016. Published by Elsevier Masson SAS.

StephenW

临床RES肝脏病Gastroenterol。 2016年2月PII：S2210-7401（16）00002-4。 DOI：10.1016 / j.clinre.2015.12.011。 [打印EPUB提前]
慢性乙肝和脂肪肝：在临床管理问题。
库马尔R1，皇家蜂吴作栋G2。
作者信息

    胃肠病学和肝病，新加坡中央医院，新加坡教研室;里昂（CRCL），INSERM U1052，里昂，法国癌症研究中心。电子地址：[email protected]。
    胃肠病学和肝病，新加坡中央医院，新加坡，新加坡的教研室。

抽象

具有增加的非酒精性脂肪肝的发生，伴随乙型肝炎和脂肪肝的存在正在成为临床实践中更常见。在临床实践中，B型肝炎和脂肪肝的伴随存在引起在临床管理的实际问题。对于临床医生能够在升高的丙氨酸转氨酶（ALT）的情况下，处理的方式和在决定潜在的原因，无论它们是与慢性乙型肝炎或到非酒精性脂肪性肝炎（NASH）决定它变得更加困难。随着不断发展的实践和变化的非酒精性脂肪性肝病，慢性乙肝的知识，对疾病的主要临床判断成为他们必不可少的共存。这个简短的审查旨在审查现有伴随这两种疾病的频率现有证据，区分两个，预后的可能途径，治疗和可能的共同通路的结果。

版权所有©2016年出版由Elsevier马森SAS。